Diclofenac and metformin synergistic dose dependent inhibition of hamster fibrosarcoma, rescued with mebendazole

In conclusion, diclofenac and metformin combination may be recommended for potential use in oncology, due to synergistic anticancer effect in doses achievable in humans.PMID:37738800 | DOI:10.1016/j.biopha.2023.115528

Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - September 22, 2023 Category: Drugs & Pharmacology Authors: Du šica J Popović Kosta J Popovi ć Dejan Miljkovi ć Jovan K Popovi ć Du šan Lalošević Mihalj Po ša Zana Doli ćanin Ivan Čapo Source Type: research